Search results for "Kaplan-Meier"

showing 10 items of 359 documents

A two-cohort feasibility study on polyglycolic acid yarn implantation for abolition of saphenous vein reflux

2017

The objective of this study was to evaluate the feasibility and safety of a polyglycolic acid (PGA) yarn implant for nonthermal ablation of saphenous vein reflux.In two consecutive cohort studies (TAHOE I and TAHOE II), the feasibility of abolition of great saphenous vein (GSV) reflux by implantation of a PGA yarn was tested under ultrasound guidance in 51 and 30 patients, respectively. The use of tumescent local anesthesia was not required. Graduated compression stockings and thrombosis prophylaxis with low-molecular-weight heparin were used for 2 weeks after intervention in the first study only.Of 81 enrolled patients, 77 (95%) were available at 6-month follow-up. Complete occlusion of th…

AdultMalemedicine.medical_specialtyTime FactorsBiocompatible MaterialsKaplan-Meier Estimate030204 cardiovascular system & hematologyVaricose Ulcer03 medical and health sciences0302 clinical medicineFibrinolytic AgentsAbsorbable ImplantsOcclusionmedicineHumansSaphenous VeinLocal anesthesia030212 general & internal medicineVeinUltrasonography InterventionalAgedRetrospective StudiesUltrasonography Doppler DuplexWound Healingbusiness.industryDominican RepublicEndovascular ProceduresGreat saphenous veinRefluxRetrospective cohort studyMiddle Agedmedicine.diseaseThrombosisConfidence intervalSurgeryEuropeTreatment Outcomemedicine.anatomical_structureVenous InsufficiencyFeasibility StudiesFemaleSurgeryCardiology and Cardiovascular MedicinebusinessPolyglycolic AcidStockings CompressionJournal of Vascular Surgery: Venous and Lymphatic Disorders
researchProduct

Delay between symptoms and surgery for carotid artery stenosis: modification of our practice.

2014

Recent data from the literature concerning symptomatic carotid stenosis show that the long-term benefits of surgery are greater when the surgery is performed soon after the neurologic event, ideally within 2 weeks. Since 2009, following recommendations, we decided to perform surgery as quick as possible. The aim of the study was to determine whether this approach increased postoperative morbimortality and the way it could change our practice.Using a prospective database containing a consecutive and continuous series of 1,500 carotid endarterectomies performed between 2003 and 2012, we extracted the records concerning the 417 symptomatic carotid stenoses (27.8%). We compared the 30-day and l…

AdultMalemedicine.medical_specialtyTime FactorsDatabases FactualCarotid arteriesAmaurosis FugaxComorbidityKaplan-Meier EstimateDisease-Free SurvivalTime-to-TreatmentCarotid stenosesRisk FactorsmedicineHumansCarotid StenosisStrokeAgedRetrospective StudiesAged 80 and overEndarterectomy Carotidbusiness.industryMortality rateRetrospective cohort studyGeneral MedicineAmaurosis fugaxMiddle Agedmedicine.diseaseComorbiditySurgeryStrokeStenosisTreatment OutcomeIschemic Attack TransientSurgeryFemaleFrancemedicine.symptomCardiology and Cardiovascular MedicinebusinessAnnals of vascular surgery
researchProduct

FA01.02: THE EFFECT OF POSTOPERATIVE COMPLICATIONS AFTER MIE ON LONG-TERM SURVIVAL: A RETROSPECTIVE, MULTI-CENTER COHORT STUDY.

2018

Abstract Background Esophagectomy has a high incidence of postoperative morbidity. Complications lead to a decreased short-term survival, however the influence of those complications on long-term survival is still unclear. Most of the performed studies are small, single center cohort series with inconclusive or conflicting results. Minimally invasive esophagectomy (MIE) has been shown to be associated with a reduced postoperative morbidity. In this study, the influence of complications on long-term survival for patients with esophageal cancer undergoing a MIE were investigated. Methods Data was collected from the EsoBenchmark database, a collaboration of 13 high-volume centers routinely per…

AdultMalemedicine.medical_specialtyTime FactorsDatabases FactualEsophageal Neoplasmsmedicine.medical_treatmentAnastomotic LeakKaplan-Meier EstimateSingle Center03 medical and health sciencesPostoperative Complications0302 clinical medicineSDG 3 - Good Health and Well-beingmedicineHumansMinimally Invasive Surgical ProceduresAgedRetrospective Studiesbusiness.industryIncidence (epidemiology)GastroenterologyRetrospective cohort studyGeneral MedicineMiddle AgedEsophageal cancermedicine.diseaseSurgeryEsophagectomyLog-rank testTreatment OutcomeEsophagectomy030220 oncology & carcinogenesisCohortFemale030211 gastroenterology & hepatologybusinessCohort study
researchProduct

Prognostic Value of a Comprehensive Cardiac Magnetic Resonance Assessment Soon After a First ST-Segment Elevation Myocardial Infarction

2009

ObjectivesTo evaluate the prognostic value of a comprehensive cardiac magnetic resonance (CMR) assessment soon after a first ST-segment elevation myocardial infarction (STEMI).BackgroundCMR allows for a simultaneous assessment of wall motion abnormalities (WMA), WMA with low-dose dobutamine (WMA-dobutamine), microvascular obstruction, and transmural necrosis. This approach has been proven to be useful to predict late systolic recovery soon after STEMI. Its prognostic value and the relative prognostic weight of these indexes are not well-defined.MethodsWe studied 214 consecutive patients with a first STEMI treated with thrombolytic therapy or primary angioplasty discharged from hospital. In …

AdultMalemedicine.medical_specialtyTime FactorsMagnetic Resonance Imaging CineInfarctionKaplan-Meier EstimateRisk Assessmentcardiac magnetic resonanceNecrosisPredictive Value of TestsRecurrenceRisk FactorsDobutamineInternal medicinemedicineHumansThrombolytic TherapyRadiology Nuclear Medicine and imagingcardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryAgedProportional Hazards ModelsHeart Failurebusiness.industryMyocardiumAdrenergic beta-AgonistsMiddle Agedmedicine.diseaseCoronary VesselsMyocardial ContractionTreatment Outcomemyocardial infarctionRadiology Nuclear Medicine and imagingHeart failureMicrovesselscardiovascular systemCardiologyMyocardial infarction complicationsFemaleDobutamineprognosisMyocardial infarction diagnosisCardiology and Cardiovascular MedicinebusinessTIMIMacemedicine.drugJACC: Cardiovascular Imaging
researchProduct

Lung Preservation With Perfadex or Celsior in Clinical Transplantation: A Retrospective Single-Center Analysis of Outcomes.

2015

BACKGROUND Despite improvement of lung preservation by the introduction of low-potassium dextran (LPD) solution, ischemia-reperfusion injury remains a major contributor to early post-lung transplant graft dysfunction and mortality. After favorable experimental data, Celsior solution was used in our clinical lung transplant program. Data were compared with our historic LPD cohort. METHODS Between January 2002 and January 2005, 209 consecutive lung transplantations were performed with LPD. These were compared to 208 transplants between February 2005 and September 2007 with Celsior. Endpoints included posttransplant PaO2/FiO2 ratio at different timepoints after intensive care unit (ICU) admiss…

AdultMalemedicine.medical_specialtyTime FactorsOrgan Preservation SolutionsBronchiolitis obliteransKaplan-Meier EstimateSingle CenterDisaccharidesDisease-Free Survivallaw.inventionElectrolytesGlutamateslawRisk FactorsGermanymedicineHumansHistidineMannitolCitratesProportional Hazards ModelsRetrospective StudiesTransplantationLungProportional hazards modelbusiness.industryRetrospective cohort studyOrgan PreservationLength of StayMiddle Agedmedicine.diseaseIntensive care unitGlutathioneRespiration ArtificialSurgeryTransplantationIntensive Care Unitsmedicine.anatomical_structureTreatment OutcomeCohortBronchiolitisFemalePrimary Graft DysfunctionbusinessLung TransplantationTransplantation
researchProduct

Survival in young patients with intermediate-/high-risk myelofibrosis: Estimates derived from databases for non transplant patients

2009

Recent studies have suggested that allogenic stem cell transplantation (allo-SCT) might be a better treatment option, compared to drug therapy, for young patients with high-/intermediate-risk primary myelofibrosis (PMF). However, there are no controlled studies that validate this contention and allo-SCT is associated with a substantial risk of procedure-related mortality and morbidity. In a retrospective analysis of nontransplant PMF patients, who were both young (age <60 years) and with high-/intermediate-risk disease, 1- and 3-year survival estimates were 87% and 55%, 95% and 77%, 71% and 58%, respectively, involving patients seen at three different centers with expertise in PMF; these da…

AdultMalemedicine.medical_specialtyTransplantation ConditioningAdolescentmedicine.medical_treatmentbone marrow transplantationContext (language use)myelofibrosisHematopoietic stem cell transplantationKaplan-Meier EstimateSettore MED/15 - Malattie Del Sanguemyelofibrosis survivalYoung AdultPharmacotherapyInternal medicinemedicineHumansTransplantation HomologousYoung adultMyelofibrosisRetrospective Studiesbusiness.industryAge FactorsHematopoietic Stem Cell TransplantationRetrospective cohort studyHematologyMiddle Agedmedicine.diseaseSurgeryTransplantationmyelofibrosis; bone marrow transplantationPrimary MyelofibrosisFemaleTransplantation ConditioningbusinessFollow-Up Studies
researchProduct

Comparative epidemiology of stroke and acute myocardial infarction: the Dijon Vascular Project (DIVA)

2009

Despite a common pathophysiological mechanism (ie, atherosclerosis) and similar vascular risk factors, few reliable studies have compared the epidemiology of stroke and acute myocardial infarction (AMI).All first ever cases of stroke and AMI in Dijon, France (151 846 inhabitants) from 2001 to 2006 were prospectively recorded. The 30 day case fatality rates (CFRs) and vascular risk factors were assessed in both groups.Over the 6 years, 1660 events (1020 strokes and 640 AMI) were recorded. Crude incidence of stroke was higher than that of AMI (112 vs 70.2/100 000/year; p0.001). With regard to sex, the relative incidence of stroke compared with AMI was 0.88 (95% CI 0.60 to 1.29; p = 0.51) in w…

AdultMalemedicine.medical_specialtyhealth care facilities manpower and servicesHypercholesterolemiaMyocardial InfarctionKaplan-Meier Estimate030204 cardiovascular system & hematology03 medical and health sciencesSex Factors0302 clinical medicineRisk FactorsInternal medicineDiabetes mellitusEpidemiologyCase fatality rateNEUROEPIDEMIOLOGYDiabetes MellitusmedicineHumansEPIDEMIOLOGYNeuroepidemiologyRegistriesMyocardial infarctioncardiovascular diseasesStrokehealth care economics and organizationsAgedVascular diseasebusiness.industryIncidence (epidemiology)Middle Agedmedicine.disease3. Good healthSurgeryPsychiatry and Mental healthHyperglycemiaAcute DiseaseFemaleSurgeryFranceNeurology (clinical)business030217 neurology & neurosurgerySTROKE
researchProduct

Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: Early and long-term data from a retrospective observational stu…

2011

Introduction: About 30-40% of patients with acute severe ulcerative colitis (UC) fail to respond to intensive intravenous (iv) corticosteroid treatment. Iv cyclosporine and infliximab are an effective rescue therapy in steroid-refractory UC patients but up to now it is still unclear which is the best therapeutic choice. Methods: We reviewed our series of severe steroid-refractory colitis admitted consecutively since 1994 comparing two historical cohort treated with iv cyclosporine (2 mg/kg) or iv infliximab (5 mg/kg). The main outcome was the colectomy rate at 3 months, 12 months and at the end of the follow-up. Results: A total of 65 patients were included: 35 in the cyclosporine group and…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentAnti-Inflammatory AgentsAzathioprineKaplan-Meier EstimateGastroenterologyCohort StudiesRefractoryInternal medicinemedicineHumansColitisColectomyRetrospective StudiesColectomybiologybusiness.industryC-reactive proteinGastroenterologyAntibodies MonoclonalRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseCombined Modality TherapyUlcerative colitisInfliximabInfliximabSurgeryLogistic ModelsTreatment OutcomeCyclosporinebiology.proteinColitis UlcerativeFemalebusinessImmunosuppressive AgentsFollow-Up Studiesmedicine.drugJournal of Crohn's and Colitis
researchProduct

Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia

2021

In β-thalassaemia, the severity of inherited β-globin gene mutations determines the severity of the clinical phenotype at presentation and subsequent transfusion requirements. However, data on associated long-term outcomes remain limited. We analysed data from 2109 β-thalassaemia patients with available genotypes in a global database. Genotype severity was grouped as β0 /β0 , β0 /β+ , β+ /β+ , β0 /β++ , β+ /β++ , and β++ /β++ . Patients were followed from birth until death or loss to follow-up. The median follow-up time was 34·1 years. Mortality and multiple morbidity outcomes were analyzed through five different stratification models of genotype severity groups. Interestingly, β0 and β+ mu…

AdultMalemedicine.medical_specialtyphenotypegenotypemorbidityKaplan-Meier Estimatebeta-GlobinsGene mutationβ thalassaemiaGlobal HealthGastroenterologySeverity of Illness IndexsurvivalCohort StudiesYoung AdultInternal medicineGenotypemedicineLong term outcomesOdds RatioHumansAllelesgenotype; morbidity; mortality; phenotype; survivalProportional Hazards Modelsbusiness.industrybeta-ThalassemiaDisease ManagementHematologyPrognosisPhenotypemortalityConfidence intervalPopulation SurveillanceCohortMutationFemaleRisk of deathbusinessFollow-Up Studies
researchProduct

Peri-Tumoral Inflammatory Cell Infiltration in OSCC: A Reliable Marker of Local Recurrence and Prognosis? An Investigation Using Artificial Neural Ne…

2011

The presence of inflammatory reaction in peri-tumoural connective tissue is generally considered as a defense mechanism against cancer, but inflammation tissue in malignant transformation and early steps of oncogenesis has been recently proven to play a supporting and aggravating role in some carcinomas. Aims of this retrospective study were to evaluate in OSCCs the independent association of peri-tumoral inflammatory infiltrate (PTI) with local recurrence (LR) or survival outcome, and to verify whether PTI can be considered a marker of prognosis. Data from 211 cases of OSCC, only surgically treated between 1990 and 2000, were collected and retrospectively analyzed for PTI and the event LR…

AdultMalesurvival ratemedicine.medical_specialtyPathologyoral carcinoma recurrence survival rate markerrecurrenceImmunologyKaplan-Meier EstimateLogistic regressionLower riskGastroenterologyoral carcinomaMalignant transformationSettore MED/28 - Malattie OdontostomatologicheInternal medicinemedicineCarcinomaHumansImmunology and AllergyStage (cooking)Survival rateAgedNeoplasm StagingAged 80 and overInflammationmarkerPharmacologyUnivariate analysisbusiness.industrymarker; oral carcinoma; recurrence; survival rate;CancerMiddle AgedPrognosismedicine.diseaseTumor BurdenCarcinoma Squamous CellFemaleMouth NeoplasmsNeural Networks ComputerNeoplasm GradingbusinessInternational Journal of Immunopathology and Pharmacology
researchProduct